General Toxicology and Risk Assessment (GLP-Compliant)

Mice, Rats, Guinea Pigs and Rabbits


Routes of Administration
Oral, Dermal, Inhalation, Intravenous, Intradermal, Subcutaneous, Intramuscular, Intraperitoneal, Intranasal and Ocular


Products Handled
Agrochemicals, Pharmaceuticals, New Chemical Entities (NCE), New Biological Entities (NBE), Industrial Chemicals, Drug Impurities, Veterinary drugs, Nanomaterials, Cosmetics, Feed Additives, Medical Devices, Biosimilars, Biopesticides and other Genetically Modified Products


Guidelines Followed
OECD, KCR, ICH, EMEA, EPA, OPPTS, FDA and all other Indian and International regulatory guidelines for conduct of nonclinical environmental and safety studies


Single-dose / Special Toxicity Studies

  • Acute Toxicity Studies
  • Dermal Irritation Study
  • Eye Irritation Study
  • Skin Sensitization Study
  • Inhalation Toxicity Study
  • Local Lymph Node Assay
  • In vitro Skin Corrosion/Irritation Studies
  • Abnormal Toxicity Study
  • Immunotoxicity Studies
    Range-finding Toxicity Studies

  • Exploratory and MTD Studies by Oral and Parenteral Route (Non-GLP)
  • Flexible Design and Duration
    Subchronic Toxicity Studies

    • 28-day Studies
    • 90-day Studies
    • Flexible Design and Duration

    Chronic Toxicity Studies

    • Six month or one year studies
    • Flexible Design and Duration

    Carcinogenicity Studies

    • Combined Toxicity/Carcinogenicity Studies
    • Flexible Design

      Developmental and Reproductive Toxicology

      • Fertility and Early Embryonic Development to Implantation Study in Rats (Segment I)
      • Pre-and Post-natal Development Study in Rats (Segment III)
      • Embryo-Fetal Development (Teratology) Studies in Rats and Rabbits
      • Developmental Screening Studies (Non-GLP)
      • One or Two Generation Studies